Stay informed with the latest litigation news. Explore now
Stimulation Of Anti-Tumor Immunity Using Dendritic Cell/Tumor Cell Fusions And Anti-Cd3/Cd28 - EP2215220B1
EP2215220
- Application Number
- EP08846621A
- Filing Date
- Nov 7, 2008
- Status
- No Opposition Filed Within Time Limit
- Nov 16, 2018
- Grant Date
- Jan 10, 2018
- External Links
- Slate, Register, Google Patents
- Similar Patents facing opposition
Bibliography
The patent EP2215220B1 was granted to Beth Israel Deaconess Medical Center on Jan 10, 2018 following the initial filing on Nov 7, 2008 under the application number EP08846621A . The current legal status of the patent is No Opposition Filed Within Time Limit.
Patent Summary
Patent Family New
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents